Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TLV/INCR stock hub

TLV/INCR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TLV/INCRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
137.8M
Tel Aviv Stock Exchange
Market data

Price

Recent price action with selectable time range.

TLV/INCRTLV/INCR
Loading chart…
In the news

Latest news · TLV/INCR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-9.3
P25 n/aP50 n/aP75 n/a
ROIC-4.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TLV/INCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
197
Groups with data
11
Currency
ILS
Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Israel
Country code
IL
Employees
320
Employees Change
50%
Employees Change Percent
18.52
Enterprise value
ILA 269.7M
Exchange
Tel Aviv Stock Exchange
Financial currency
ILS
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
IL0011063760
Last refreshed
2026-05-10
Market cap
ILA 137.8M
Price
ILA 252
Price currency
ILA
Rev Per Employee
844,375x
Sector
Healthcare
Sic
2834
Symbol
tlv/INCR
Website
https://www.intercure.co

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-25.91%
EV Earnings
-7.55x
EV/FCF
20.29x
EV/Sales
1x
FCF yield
9.65%
P/B ratio
0.35x
P/S ratio
0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
-9.44%
EBITDA Margin
-3.1%
FCF margin
4.92%
Gross margin
15.06%
Gross Profit
ILA 40.7M
Gross Profit Growth
0.22%
Gross Profit Growth Q
-3.45%
Gross Profit Growth3 Y
-19.48%
Gross Profit Growth5 Y
-23.86%
Net Income
ILA -35.7M
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Pretax Margin
-16.32%
Profit Margin
-13.22%
Profit Per Employee
ILA -111,594
ROA
-2.19
Roa5y
-0.51
ROCE
-5.36
ROE
-9.27
Roe5y
-5.71
ROIC
-4.83
Roic5y
-1.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
1.93%
Cagr15y
-33.8%
Cagr1y
-56.71%
Cagr3y
-32.78%
Cagr5y
-33.93%
EPS Growth Quarters
2
EPS Growth Years
1
OCF Growth10 Y
7.87%
Revenue Growth
13.13x
Revenue Growth Q
3.4x
Revenue Growth Quarters
2x
Revenue Growth Years
1x
Revenue Growth3 Y
-0.3x
Revenue Growth5 Y
-8.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
ILA 0.37
Assets
ILA 690.6M
Cash
ILA 46.7M
Current Assets
ILA 374M
Current Liabilities
ILA 202M
Debt
ILA 178.8M
Debt Equity
ILA 0.45
Debt FCF
ILA 13.45
Equity
ILA 396.4M
Interest Coverage
-1.28
Liabilities
ILA 294.2M
Long Term Assets
ILA 316.6M
Long Term Liabilities
ILA 92.2M
Net Cash
ILA -132.1M
Net Cash By Market Cap
ILA -95.85
Net Debt Equity
ILA 0.33
Net Debt FCF
ILA 9.94
Tangible Book Value
ILA 177.3M
Tangible Book Value Per Share
ILA 3.45
WACC
7.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.48
Inventory Turnover
2.01
Net Working Capital
ILA 155.5M
Quick ratio
0.96
Working Capital
ILA 102.4M
Working Capital Turnover
ILA 1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-18.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
21.02%
1Y total return
-56.69%
200-day SMA
396
3Y total return
-69.63%
50-day SMA
250.8
50-day SMA vs 200-day SMA
50under200
5Y total return
-87.41%
All Time High
93,790,599.6
All Time High Change
-100%
All Time High Date
2007-11-01
All Time Low
44.49
All Time Low Change
466.38%
All Time Low Date
2012-07-26
ATR
13.9
Beta
0.35
Beta1y
-0.33
Beta2y
0.15
Ch YTD
-22.13
High
258.9
High52
605
High52 Date
2025-08-12
High52ch
-58.35%
Low
243.1
Low52
225.3
Low52 Date
2026-04-17
Low52ch
11.85%
Ma50ch
0.49%
Price vs 200-day SMA
-36.37%
RSI
50.28
RSI Monthly
30.2
RSI Weekly
29.08
Sharpe ratio
-1.54x
Sortino ratio
-2.1
Total Return
-18.12%
Tr YTD
-22.13
Tr15y
-99.79%
Tr1m
6.42%
Tr1w
-5.33%
Tr3m
-10.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
ILA -25.5M
Operating Income Growth Q
-43.76
Operating margin
-9.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
37,424,555%
Net Borrowing
-29,129,000
Shares Insiders
26.19%
Shares Institutions
1.62%
Shares Out
54,681,335
Shares Qo Q
29.17%
Shares Yo Y
18.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
ILA 10.9M
Average Volume
72,487.9x
Bv Per Share
7.71
CAPEX
ILA -3.5M
Ch10y
21.02
Ch15y
-99.85
Ch1m
6.42
Ch1w
-5.33
Ch1y
-56.69
Ch3m
-10.54
Ch3y
-69.63
Ch5y
-87.41
Ch6m
-44
Change
-0.36%
Change From Open
3.66
Close
252.9
Days Gap
-3.88
Depreciation Amortization
17,148,000
Dollar Volume
5,077,800
Earnings Date
2026-05-15
EBIT
ILA -25.5M
EBITDA
ILA -8.4M
EPS
ILA -0.66
F Score
4
FCF
ILA 13.3M
FCF EV Yield
4.93x
FCF Per Share
ILA 0.24
Financing CF
-46,658,000
Fiscal Year End
December
Founded
1,994
Goodwill
224,778,000
Income Tax
ILA -7.3M
Investing CF
-1,991,000
Is Primary Listing
1
Last Earnings Date
2025-12-01
Last Report Date
2025-06-30
Last Split Date
2021-04-08
Last Split Type
Reverse
Ma150
350.8
Ma150ch
-28.16%
Ma20
248.4
Ma20ch
1.47%
Net CF
-31,852,000
Next Earnings Date
2026-05-15
Open
243.1
P FCF Ratio
10.37
P OCF Ratio
8.18
Position In Range
56.33
Ppne
105,046,000
Price Date
2026-05-08
Ptbv Ratio
0.78
Relative Volume
0.28x
Revenue
270,200,000x
SBC By Revenue
0.9x
Share Based Comp
2,429,000
Tax By Revenue
-2.71x
Tr6m
-44%
Volume
20,150
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TLV/INCR pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/INCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-56.7%
S&P 500 1Y: n/a
3Y total return
-69.6%
S&P 500 3Y: n/a
5Y total return
-87.4%
S&P 500 5Y: n/a
10Y total return
+21.0%
S&P 500 10Y: n/a
Ownership

Who owns TLV/INCR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.6%
Share of float held by funds and institutions
Insider ownership
+26.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+18.1%
Negative means the company is buying back shares.
Technical

TLV/INCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.3
Neutral momentum band
Price vs 200-day MA
-36.4%
50/200-day relationship not available
Beta (5Y)
0.35
Less volatile than the market
Sharpe ratio
-1.54
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TLV/INCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/INCR stock rating?

tlv/INCR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/INCR analysis?

The full report lives at /stocks/tlv/INCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/INCR?

The latest report frames tlv/INCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/INCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.